Medicare Enrolled
Dr. Brett Milford, D.O.
Cardiovascular Disease · Sarasota, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Milford from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Milford? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Milford
Dr. Brett Milford is a cardiovascular disease in Sarasota, FL, with 13 years in practice. Based on federal Medicare data, Dr. Milford performed 7,593 Medicare services across 4,310 unique beneficiaries.
Between the years covered by Open Payments, Dr. Milford received a total of $9,389 from 28 pharmaceutical and/or device companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Milford is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 12% volume in FL$ $9,389 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,593
Medicare services
Top 12% in FL for cardiovascular disease
4,310
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~584 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 1,500 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,339 | $91 | $218 |
| Hospital follow-up visit, moderate complexity | 392 | $62 | $149 |
| Electrocardiogram (EKG), 12-lead | 335 | $10 | $41 |
| Blood draw (venipuncture) | 329 | $8 | $14 |
| Comprehensive metabolic blood panel | 283 | $10 | $30 |
| Lipid panel (cholesterol and triglycerides) | 276 | $13 | $38 |
| Ct scan of heart with evaluation of blood vessel calcium | 255 | $70 | $425 |
| Echocardiogram, transthoracic | 248 | $140 | $476 |
| Regadenoson injection (Lexiscan) for heart stress test | 216 | $45 | $123 |
| Complete blood count (CBC) with differential | 194 | $8 | $22 |
| Ultrasound of both sides of head and neck blood flow | 183 | $132 | $404 |
| Initial hospital admission, high complexity | 179 | $130 | $415 |
| New patient office visit (45-59 min) | 170 | $119 | $334 |
| Creatine kinase (cardiac enzyme) level, total | 147 | $6 | $19 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 144 | $88 | $236 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 142 | $26 | $70 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 139 | $19 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 109 | $48 | $157 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 72 | $330 | $1,010 |
| Remote pacemaker/defibrillator monitoring, 90 days | 71 | $16 | $69 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 70 | $10 | $26 |
| Remote pacemaker monitoring, 90 days | 60 | $22 | $69 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 52 | $313 | $798 |
| Office visit, established patient (20-29 min) | 48 | $70 | $150 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 36 | $17 | $45 |
| Cardiac catheterization | 35 | $190 | $693 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 34 | $9 | $28 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 34 | $117 | $442 |
| Ultrasound of leg arteries or artery grafts | 31 | $169 | $589 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 30 | $19 | $56 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 29 | $14 | $57 |
| Electrocardiogram (ecg) 2-day continuous | 28 | $11 | $62 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 26 | $2,038 | $4,406 |
| Programming of dual lead pacemaker system | 26 | $56 | $143 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 25 | $130 | $480 |
| Basic metabolic blood panel | 21 | $8 | $24 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $84 | $239 |
| Coronary stent placement | 20 | $455 | $1,309 |
| Ultrasound of heart, follow-up | 20 | $19 | $58 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $83 | $247 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $14 | $41 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $2 | $8 |
| Initial hospital admission, moderate complexity | 19 | $82 | $283 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 17 | $114 | $561 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 16 | $76 | $211 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $17 | $45 |
| Hospital follow-up visit, high complexity | 16 | $94 | $213 |
| Ct scan of blood vessels and grafts of heart with contrast | 15 | $216 | $1,356 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $58 | $211 |
| Blood creatinine level | 14 | $5 | $15 |
| Ultrasound scan of abdominal aorta | 13 | $102 | $223 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $36 | $91 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $537 | $1,468 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.2% high complexity
33.4% medium
59.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,389
Total received (2018-2024)
Avg $1,341/year across 7 years
Top 26% in FL for cardiovascular disease
28
Companies
123
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,185 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$204 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$532
2023$532
2022$3,226
2021$859
2020$120
2019$100
2018$4,020
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Penumbra, Inc.
$3,101
Boston Scientific Corporation
$2,721
Abbott Laboratories
$627
CVRx, Inc.
$487
Janssen Pharmaceuticals, Inc
$435
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$384
BIOTRONIK INC.
$320
Bard Peripheral Vascular, Inc.
$253
AstraZeneca Pharmaceuticals LP
$158
EKOS Corporation
$139
ABIOMED
$138
PFIZER INC.
$69
ASAHI INTECC USA, INC.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
Inari Medical, Inc.
$53
Merck Sharp & Dohme LLC
$47
BOSTON SCIENTIFIC CORPORATION
$46
Medtronic, Inc.
$44
Novartis Pharmaceuticals Corporation
$38
Arrow International, Inc.
$34
Cardiovascular Systems Inc.
$29
Philips North America LLC
$25
Daiichi Sankyo Inc.
$22
E.R. Squibb & Sons, L.L.C.
$20
Alnylam Pharmaceuticals Inc.
$19
SOBI, INC
$19
Kiniksa Pharmaceuticals International, plc
$17
Novo Nordisk Inc
$14
Top 3 companies account for 68.7% of total payments
Associated products mentioned in payments ›
(CK7) Extended Holter · ANGIOJET · ASAHI PTCA Guide Wire · ASSURITY · AZURE XT DR MRI SURESCAN · Arcalyst · BIOMONITOR · BRILINTA · Barostim Neo System · CARDIOMEMS · CROSSER · Catheter - Specialty Access · Coronary Orbital Atherectomy System · DOPTELET · Diamondback Coronary · Dragonfly OCT · EKOSONIC · ELIQUIS · ELUVIA · FARXIGA · FLOWTRIEVER CATHETER · GENERAL THROMBECTOMY · GENERAL STRUCTURAL HEART · Hi-Torque Connect guide wire · INJECTAFER · Impella · Indigo System · JARDIANCE · KEYTRUDA · KISQALI · LEQVIO · LifeVest · MitraClip System · ONPATTRO · Optis Coronary Imaging System · PCI Optimization · PressureWire FFR · S · Supera peripheral stent system · Trifecta GT Tissue Heart Valve · VERQUVO · VYNDAQEL · Venovo · WATCHMAN · Wegovy · XARELTO · Xience Sierra Coronary Stent
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $124 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
82
Per 100K population
18.3
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Milford is a clinical cardiology specialist, with above-average Medicare volume (top 12% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Milford experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Milford performed 1,500 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Milford receive payments from pharmaceutical companies?
Yes. Dr. Milford received a total of $9,389 from 28 companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Milford's costs compare to other cardiovascular diseases in Sarasota?
Dr. Milford's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Milford) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Sarasota
Browse cardiovascular diseases in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology